Advanced search

Vol 17, No 6 (2021)
Review paper
Published online: 2021-04-20

open access

View PDF Download PDF file
Page views 6113
Article views/downloads 778
Get Citation

Connect on Social Media

Connect on Social Media

Causes of BIA-ALCL: a summary of the current state of knowledge

Agnieszka Ławnicka1, Sławomir Cieśla1, Piotr Pluta2, Aleksandra Przybylska3, Dawid Murawa14
DOI: 10.5603/OCP.2021.0013
Oncol Clin Pract 2021;17(6):285-290.

Abstract

The reasons for the development of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) have recently been quite a popular topic. The main interest is among plastic surgeons, surgical oncologists, hematologists, and oncologists. Over the past decade, numerous scientific papers on this subject have been published. Potential etiopathogenetic factors include the type of implants, biofilm, inflammation, microtrauma, and genetic mutations. None of the above potential causes have been adequately proven by scientific evidence; anyway, they should not be considered separately, as they are likely to coexist. Further research and exchange of experience among doctors and scientists are necessary to determine the leading etiopathogenetic factor. Its emergence would contribute to the rise of the possibility of using effective preventive measures in patients undergoing breast implant surgery and perhaps even eliminating BIA-ALCL.

Keywords: BIA-ALCL etiological factorsbreast implantsbreast implant-associated anaplastic large cell lymphomacomplications of oncological and plastic surgery

Article available in PDF format

View PDF Download PDF file

References

  1. Hedén P, Stark B. [Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)]. Lakartidningen. 2018; 115.
    PubMed
  2. Miranda RN, Medeiros LJ, Ferrufino-Schmidt MC, et al. Pioneers of Breast Implant-Associated Anaplastic Large Cell Lymphoma: History from Case Report to Global Recognition. Plast Reconstr Surg. 2019; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma): 7S–714S.
    CrossRefPubMed
  3. BIA-ALCL Physician Resources [Internet]. American Society of Plastic Surgeons. https://www.plasticsurgery.org/for-medical-professionals/health-policy/bia-alcl-physician-resources (24.04.2020).
  4. Rastogi P, Deva AK, Prince HM. Breast Implant-Associated Anaplastic Large Cell Lymphoma. Curr Hematol Malig Rep. 2018; 13(6): 516–524.
    CrossRefPubMed
  5. Collett DJ, Rakhorst H, Lennox P, et al. Current Risk Estimate of Breast Implant-Associated Anaplastic Large Cell Lymphoma in Textured Breast Implants. Plast Reconstr Surg. 2019; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma): 30S–40S.
    CrossRefPubMed
  6. Calobrace MB, Schwartz MR, Zeidler KR, et al. Long-Term Safety of Textured and Smooth Breast Implants. Aesthet Surg J. 2017; 38(1): 38–48.
    CrossRefPubMed
  7. Allergan Recalls Natrelle Biocell Textured Breast Implants Due to Risk of BIA-ALCL Cancer [Internet]. US FOOD&DRUG ADMINISTRATION. https://www.fda.gov/medical-devices/medical-device-recalls/allergan-recalls-natrelle-biocell-textured-breast-implants-due-risk-bia-alcl-cancer (24.04.2020).
  8. General and Plastic Surgery Devices Panel March 25-26, 2019 Mentor Briefing Package[Internet]. US FOOD&DRUG ADMINISTRATION. https://www.fda.gov/media/123013/ (24.04.2020).
  9. Peters W, Young V, Jerina K. Biomaterials in Plastic Surgery: Breast Implants. Woodhead Publishing 2012: 98.
  10. Hamdi M. Association Between Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Risk and Polyurethane Breast Implants: Clinical Evidence and European Perspective. Aesthet Surg J. 2019; 39(Suppl_1): S49–S54.
    CrossRefPubMed
  11. Magnusson M, Beath K, Cooter R, et al. The Epidemiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma in Australia and New Zealand Confirms the Highest Risk for Grade 4 Surface Breast Implants. Plast Reconstr Surg. 2019; 143(5): 1285–1292.
    CrossRefPubMed
  12. Blombery P, Thompson ER, Jones K, et al. Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma. Haematologica. 2016; 101(9): e387–e390.
    CrossRefPubMed
  13. O'Shea JJ, Schwartz DM, Villarino AV, et al. The JAK-STAT pathway: impact on human disease and therapeutic intervention. Annu Rev Med. 2015; 66: 311–328.
    CrossRefPubMed
  14. Thomas SJ, Snowden JA, Zeidler MP, et al. The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours. Br J Cancer. 2015; 113(3): 365–371.
    CrossRefPubMed
  15. Oishi N, Miranda RN, Feldman AL. Genetics of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). Aesthet Surg J. 2019; 39(Suppl_1): S14–S20.
    CrossRefPubMed
  16. Gristina AG. Biomaterial-centered infection: microbial adhesion versus tissue integration. Science. 1987; 237(4822): 1588–1595.
    CrossRefPubMed
  17. Chagnot C, Zorgani MA, Astruc T, et al. Proteinaceous determinants of surface colonization in bacteria: bacterial adhesion and biofilm formation from a protein secretion perspective. Front Microbiol. 2013; 4: 303.
    CrossRefPubMed
  18. Habimana O, Semião A, Casey E. The role of cell-surface interactions in bacterial initial adhesion and consequent biofilm formation on nanofiltration/reverse osmosis membranes. Journal of Membrane Science. 2014; 454: 82–96.
    CrossRef
  19. Rochford ETJ, Richards RG, Moriarty TF. Influence of material on the development of device-associated infections. Clin Microbiol Infect. 2012; 18(12): 1162–1167.
    CrossRefPubMed
  20. Tieszer C, Reid G, Denstedt J. Conditioning film deposition on ureteral stents after implantation. J Urol. 1998; 160(3 Pt 1): 876–881.
    CrossRefPubMed
  21. Costerton JW, Montanaro L, Arciola CR. Biofilm in implant infections: its production and regulation. Int J Artif Organs. 2005; 28(11): 1062–1068.
    CrossRefPubMed
  22. Jacombs A, Tahir S, Hu H, et al. In vitro and in vivo investigation of the influence of implant surface on the formation of bacterial biofilm in mammary implants. Plast Reconstr Surg. 2014; 133(4): 471e–480e.
    CrossRefPubMed
  23. Hu H, Jacombs A, Vickery K, et al. Chronic biofilm infection in breast implants is associated with an increased T-cell lymphocytic infiltrate: implications for breast implant-associated lymphoma. Plast Reconstr Surg. 2015; 135(2): 319–329.
    CrossRefPubMed
  24. Hu H, Johani K, Almatroudi A, et al. Bacterial Biofilm Infection Detected in Breast Implant-Associated Anaplastic Large-Cell Lymphoma. Plast Reconstr Surg. 2016; 137(6): 1659–1669.
    CrossRefPubMed
  25. Clemens MW, DeCoster RC, Fairchild B, et al. Finding Consensus After Two Decades of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Semin Plast Surg. 2019; 33(4): 270–278.
    CrossRefPubMed
  26. Sorotos M, Longo B, Amorosi V, et al. Macrotextured Breast Implants with Defined Steps to Minimize Bacterial Contamination around the Device: Experience in 42,000 Implants. Plast Reconstr Surg. 2018; 142(3): 412e–413e.
    CrossRefPubMed
  27. Ryan MP, Adley CC. The antibiotic susceptibility of water-based bacteria Ralstonia pickettii and Ralstonia insidiosa. J Med Microbiol. 2013; 62(Pt 7): 1025–1031.
    CrossRefPubMed
  28. Wee AT, Morrey BF, Sanchez-Sotelo J. The fate of elbows with unexpected positive intraoperative cultures during revision elbow arthroplasty. J Bone Joint Surg Am. 2013; 95(2): 109–116.
    CrossRefPubMed
  29. Ryan MP, Adley CC. Ralstonia spp.: emerging global opportunistic pathogens. Eur J Clin Microbiol Infect Dis. 2014; 33(3): 291–304.
    CrossRefPubMed
  30. Coussens L, Werb Z. Inflammation and cancer. Nature. 2002; 420(6917): 860–867.
    CrossRef
  31. Stefanko E, Wróbel T. Etiopatogeneza infekcyjna chłoniaków. Hematol. 2010(1): 288–295.
  32. Kadin ME, Deva A, Xu H, et al. Biomarkers Provide Clues to Early Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Aesthet Surg J. 2016; 36(7): 773–781.
    CrossRefPubMed
  33. Bizjak M, Selmi C, Praprotnik S, et al. Silicone implants and lymphoma: The role of inflammation. J Autoimmun. 2015; 65: 64–73.
    CrossRefPubMed
  34. Handel N, Gutierrez J. Long-term safety and efficacy of polyurethane foam-covered breast implants. Aesthet Surg J. 2006; 26(3): 265–274.
    CrossRefPubMed
  35. Brody GS. The Case against Biofilm as the Primary Initiator of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Plast Reconstr Surg. 2016; 137(4): 766e–767e.
    CrossRefPubMed
  36. Clemens MW, Nava MB, Rocco N, et al. Understanding rare adverse sequelae of breast implants: anaplastic large-cell lymphoma, late seromas, and double capsules. Gland Surg. 2017; 6(2): 169–184.
    CrossRefPubMed
  37. Kaartinen I, Sunela K, Alanko J, et al. Breast implant-associated anaplastic large cell lymphoma - From diagnosis to treatment. Eur J Surg Oncol. 2017; 43(8): 1385–1392.
    CrossRefPubMed
  38. Wise LA, Palmer JR, Boggs DA, et al. Abuse victimization and risk of breast cancer in the Black Women's Health Study [corrected]. Cancer Causes Control. 2011; 22(4): 659–669.
    CrossRefPubMed
  39. Rigby JE, Morris JA, Lavelle J, et al. Can physical trauma cause breast cancer? Eur J Cancer Prev. 2002; 11(3): 307–311.
    CrossRefPubMed
  40. Kuraishy A, Karin M, Grivennikov SI. Tumor promotion via injury- and death-induced inflammation. Immunity. 2011; 35(4): 467–477.
    CrossRefPubMed
  41. Center for Devices and Radiological Health [Internet]. U.S. Food and Drug Administration. Anaplastic large cell lymphoma (ALCL) in women with breast implants: preliminary FDA findings and analysis. http://www.fda.gov/downloads/MedicalDevices/ProductsandMedicalProcedures/Implant- sandProsthetics/BreastImplants/UCM240003 (24.04.2020).
  42. Pupka D, Sawicki T, Sikora J, et al. Zakażenie miejsca operowanego – postępowanie. Chirurgia po Dyplomie. 2019; 02.
  43. Cordeiro PG, Ghione P, Ni A, et al. Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implants. J Plast Reconstr Aesthet Surg. 2020; 73(5): 841–846.
    CrossRefPubMed
  44. Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Registry. ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04220970 (24.10.2020).

About cookies

Necessary cookies

Allways active

These cookies are necessary for the proper display and operation of the website. Blocking them may cause the website to malfunction.

Analytical cookies

As part of our website, we use analytical tools, such as Google Analytics, that allow us to verify website traffic. These tools may require the use of cookies.

Community cookies

These are cookies associated with the social networks we use. Accepting them will allow us to associate your visit to the site with our social media profiles.

Marketing cookies

These are cookies responsible for carrying out advertising and marketing activities - consenting to their use will allow us to target you with advertisements based on your previous activities within our website.

Oncology in Clinical Practice

About Via Medica Advertising
Bookstore (Ikamed) TVMed
News
Copyright © 2023 Via Medica Regulations Cookie policy Privacy policy Legal Notice